CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Pilar Sánchez-Blázquez

OPENALEX: A5033386165↗ORCID: 0000-0002-7211-4504↗

Affiliations

Organizations

Consejo Superior de Investigaciones Científicasauthorship · ES Instituto Cajalauthorship · ES

Public evidence

3 connected articles

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.2020 · Europe PMC Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.2018 · PubMed Central Open Access The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia2014 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Pilar Sánchez-Blázquez - Medical Cannabis Research Engine